WAVE LIFE SCIENCES LTD. Public Float
WAVE LIFE SCIENCES LTD. (WVE) had Public Float of $851.01 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $851.01M.
- 2024-06-28: Entity Public Float $488.71M.
- 2023-06-30: Entity Public Float $258.75M.
- 2022-06-30: Entity Public Float $205.33M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $851.01M 10-K/A · filed 2026-04-30 |
| 2024-06-28 | $488.71M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $258.75M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $205.33M 10-K/A · filed 2023-05-05 |
| 2021-06-30 | $269.68M 10-K/A · filed 2022-04-28 |
| 2020-06-30 | $267.10M 10-K/A · filed 2021-04-30 |
| 2019-06-28 | $631.49M 10-K/A · filed 2020-04-29 |
| 2018-06-29 | $746.01M 10-K · filed 2019-03-01 |
| 2017-06-30 | $288.72M 10-K · filed 2018-03-12 |
| 2016-06-30 | $221.17M 10-K · filed 2017-03-16 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |